David Egan
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Musculoskeletal pain and rehabilitation
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
- Musculoskeletal pain and rehabilitation 3
-
- Laser-Plasma Interactions and Diagnostics 5
- Co-authors
- Einas S. Al-Eisa (4 shared papers)Richard J. Wassersug (3 shared papers)Kevin J. Deluzio (2 shared papers)Colin N. Danson (4 shared papers)David Hillier (4 shared papers)Stephen P. Elsmere (3 shared papers)Nicholas W. Hopps (4 shared papers)Andrew Owen (2 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)Applied Optics (2 papers)Veterinary Record (2 papers)Spine (2 papers)Plasma Physics and Controlled Fusion (1 paper)
- Partner nations
- United KingdomCanadaGermany
In The Last Decade
David Egan
34 papers receiving 815 citations
Peers
Comparison fields: 5 of 91
- Pharmacology 248
- Infectious Diseases 147
- Pharmacology 101
- Nuclear and High Energy Physics 106
- Equine 7
Countries citing papers authored by David Egan
This map shows the geographic impact of David Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Egan more than expected).
Fields of papers citing papers by David Egan
This network shows the impact of papers produced by David Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Egan. The network helps show where David Egan may publish in the future.
Co-authors
The 25 scholars most cited alongside David Egan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 156 | |
| 2 | 2006 | 105 | |
| 3 | 2011 | 90 | |
| 4 | 2006 | 65 | |
| 5 | 2013 | 57 | |
| 6 | 2013 | 54 | |
| 7 | 2015 | 52 | |
| 8 | 1987 | 48 | |
| 9 | 2011 | 42 | |
| 10 | 2004 | 40 | |
| 11 | 2013 | 39 | |
| 12 | 1996 | 21 | |
| 13 | 2004 | 11 | |
| 14 | 1995 | 10 | |
| 15 | 1970 | 9 | |
| 16 | 2012 | 9 | |
| 17 | 2018 | 9 | |
| 18 | 2014 | 6 | |
| 19 | 2017 | 6 | |
| 20 | 1996 | 5 |
About David Egan
David Egan is a scholar working on Pharmacology, Nuclear and High Energy Physics, Pharmacology, Pathology and Forensic Medicine and Education, having authored 39 papers that have together received 864 indexed citations. Recurring topics across this work include Laser-Plasma Interactions and Diagnostics (5 papers), School Choice and Performance (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Laser-Matter Interactions and Applications (4 papers), Musculoskeletal pain and rehabilitation (3 papers), Advanced Fiber Optic Sensors (3 papers), Spine and Intervertebral Disc Pathology (3 papers) and Heavy Metal Exposure and Toxicity (2 papers). The work is most often cited by research in Pharmacology (248 citations), Infectious Diseases (147 citations), Pharmacology (101 citations), Nuclear and High Energy Physics (106 citations) and Equine (7 citations). David Egan has collaborated with scholars based in United Kingdom, Canada and Germany. Frequent co-authors include Einas S. Al-Eisa, Richard J. Wassersug, Kevin J. Deluzio, Colin N. Danson, David Hillier, Stephen P. Elsmere, Nicholas W. Hopps, Andrew Owen, Joan H. Cole and Michael J. Norman. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Applied Optics, Veterinary Record, Spine and Plasma Physics and Controlled Fusion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.